Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for Doha Declaration
[Guest post] Revocations, special compulsory licenses, patent strategies & COVID-19: A note on Indian Patent Law [Guest post] Revocations, special compulsory licenses, patent strategies & COVID-19: A note on Indian Patent Law Reviewed by Frantzeska Papadopoulou on Monday, May 11, 2020 Rating: 5
What limitations does TRIPS put on compulsory licensing? What limitations does TRIPS put on compulsory licensing? Reviewed by Darren Smyth on Thursday, March 15, 2012 Rating: 5
The First, but of how many? India grants compulsory licence for Bayer drug Sorafenib The First, but of how many? India grants compulsory licence for Bayer drug Sorafenib Reviewed by Darren Smyth on Wednesday, March 14, 2012 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.